Kiyohiko Kurai

Suggest Changes
Learn More
A comparison was made of the results obtained in separate Phase I studies conducted in Japan on a recombinant hepatitis B vaccine (HBX-R) and a plasma-derived hepatitis B vaccine (H-B-VAX).(More)